JP Patent

JP7665686B2 — ピリド［１，２－ａ］ピリミジン－４－オン誘導体の新規な形態、その製剤およびその製造プロセス

Assigned to F Hoffmann La Roche AG · Expires 2025-04-21 · 1y expired

What this patent protects

Patent listed against Evrysdi.

Drugs covered by this patent

Evrysdi (RISDIPLAM) · Roche

Patent Metadata

Patent number: JP7665686B2
Jurisdiction: JP
Classification: —
Expires: 2025-04-21
Drug substance claim: No
Drug product claim: No
Assignee: F Hoffmann La Roche AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.